Biostatistics Shared Resource

Publications

Tocilizumab among intensive care unit COVID-19 patients: A multi-center observational study. Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S, Sinclaire BA, Bednarz U,  Marafelias M, Hansen E,  Siegel DS, Goy A,  Pecora AL, Sawczuk IS, Koniaris LS, Simwenyi M, Varga DW, Tank LK,  Stein AA,  Allusson V, Lin GS, Oser WF, Tuma RA,  Reichman J,  Brusco L,  Carpenter KL,  Costanzo EJ,  Vivona V,  Goldberg SL.  Lancet Rheumatology. 2020 Aug 14. doi: 10.1016/S2665-9913(20)30277-0. PubMed  PMID: 32838323

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study. Ip A, Ahn J, Zhou Y, Goy AH, Hansen E, Pecora AL, Sinclaire BA, Bednarz U, Marafelias M, Mathura S, Sawczuk IS, Underwood JP, Walker DM, Prasad R, Sweeney RL, Ponce MG, LaCapra S, Cunningham FJ, Calise AG, Pulver BK, Ruocco D, Mojares GE, Eagan MP, Ziontz KL, Mastrokyriakos P, Goldberg SL. BMC Infect Dis. 2021 Jan 14;21(1):72. doi: 10.1186/s12879-021-05773-w. PMID: 33446136

Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies. Biology of Blood and Marrow Transplantation. Baker M, Wang H, Rowley S, Cai L, Pecora AL, Skarbnik A, Vesole D, Adler-Brecher B, Kim D, Donato ML. Biol Blood Marrow Transplant 2016; 22(11):2047-55, doi:10.1016/j.bbmt.2016.08.003. Epub 2016 Aug 10. PubMed PMID: 27522040.

Publications Supported by the Biostatistics Shared Resource

All publications supported by the Biostatistics Shared Resource can be found here.